These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307 [TBL] [Abstract][Full Text] [Related]
3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]
5. Testosterone deficiency in older men: a problem worth treating. McHenry Martin C Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515 [TBL] [Abstract][Full Text] [Related]
6. New horizons in testosterone and the ageing male. Ahern T; Wu FC Age Ageing; 2015 Mar; 44(2):188-95. PubMed ID: 25666224 [TBL] [Abstract][Full Text] [Related]
7. Testosterone administration in older men. Matsumoto AM Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401 [TBL] [Abstract][Full Text] [Related]
8. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM; Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706 [TBL] [Abstract][Full Text] [Related]
9. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. Reyes-Vallejo L; Lazarou S; Morgentaler A J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment. Raynaud JP; Gardette J; Rollet J; Legros JJ BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726 [TBL] [Abstract][Full Text] [Related]
11. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men. Dinsmore WW; Wyllie MG BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877 [TBL] [Abstract][Full Text] [Related]
14. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population. Zhang XW; Liu ZH; Hu XW; Yuan YQ; Bai WJ; Wang XF; Shen H; Zhao YP Chin Med J (Engl); 2012 Nov; 125(21):3806-10. PubMed ID: 23106878 [TBL] [Abstract][Full Text] [Related]
15. Treatment of primary hypogonadism in men by the transdermal administration of testosterone. Findlay JC; Place V; Snyder PJ J Clin Endocrinol Metab; 1989 Feb; 68(2):369-73. PubMed ID: 2493029 [TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies. Turchi P; Simi S; Pescatori ES J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628 [TBL] [Abstract][Full Text] [Related]
18. MY APPROACH to testosterone replacement in older men. Walsh JP Trends Cardiovasc Med; 2016 Apr; 26(3):295-6. PubMed ID: 26868452 [No Abstract] [Full Text] [Related]
19. Can testosterone level be a good predictor of late-onset hypogonadism? Heidari R; Sajadi H; Pourmand A; Pourmand G Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]